Phathom Pharmaceuticals's total assets for Q2 2025 were $250.22M, a decrease of -14.95% from the previous quarter. PHAT total liabilities were $656.05M for the fiscal quarter, a 3.71% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.